These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The role of efflux pumps in Bacteroides fragilis resistance to antibiotics. Ghotaslou R; Yekani M; Memar MY Microbiol Res; 2018 May; 210():1-5. PubMed ID: 29625653 [TBL] [Abstract][Full Text] [Related]
9. BmeRABC5 is a multidrug efflux system that can confer metronidazole resistance in Bacteroides fragilis. Pumbwe L; Chang A; Smith RL; Wexler HM Microb Drug Resist; 2007; 13(2):96-101. PubMed ID: 17650960 [TBL] [Abstract][Full Text] [Related]
10. Inducible metronidazole resistance in nim-positive and nim-negative bacteroides fragilis group strains after several passages metronidazole containing columbia agar plates. Schaumann R; Petzold S; Fille M; Rodloff AC Infection; 2005 Oct; 33(5-6):368-72. PubMed ID: 16258869 [TBL] [Abstract][Full Text] [Related]
11. [Bacteroides fragilis group in non-diarrheal human feces and its antimicrobial susceptibility]. Rodríguez E; Gamboa MM; Rodríguez C; Vargas P Rev Esp Quimioter; 2006 Dec; 19(4):357-62. PubMed ID: 17235405 [TBL] [Abstract][Full Text] [Related]
12. Inactivation of MarR gene homologs increases susceptibility to antimicrobials in Bacteroides fragilis. Silva CMG; Silva DNDS; Costa SBD; Almeida JSS; Boente RF; Teixeira FL; Domingues RMCP; Lobo LA Braz J Microbiol; 2018; 49(1):200-206. PubMed ID: 28847541 [TBL] [Abstract][Full Text] [Related]
13. [Comparison of antimicrobial resistance patterns of enterotoxin gene positive and negative Bacteroides fragilis isolates]. Toprak NU; Yağci A; Celik C; Cakici O; Söyletir G Mikrobiyol Bul; 2005 Apr; 39(2):145-52. PubMed ID: 16128024 [TBL] [Abstract][Full Text] [Related]
14. Lessons learned from the anaerobe survey: historical perspective and review of the most recent data (2005-2007). Snydman DR; Jacobus NV; McDermott LA; Golan Y; Hecht DW; Goldstein EJ; Harrell L; Jenkins S; Newton D; Pierson C; Rihs JD; Yu VL; Venezia R; Finegold SM; Rosenblatt JE; Gorbach SL Clin Infect Dis; 2010 Jan; 50 Suppl 1():S26-33. PubMed ID: 20067390 [TBL] [Abstract][Full Text] [Related]
15. [The role of cell wall organization and active efflux pump systems in multidrug resistance of bacteria]. Hasdemir U Mikrobiyol Bul; 2007 Apr; 41(2):309-27. PubMed ID: 17682720 [TBL] [Abstract][Full Text] [Related]
16. Susceptibility trends of Bacteroides fragilis group and characterisation of carbapenemase-producing strains by automated REP-PCR and MALDI TOF. Treviño M; Areses P; Peñalver MD; Cortizo S; Pardo F; del Molino ML; García-Riestra C; Hernández M; Llovo J; Regueiro BJ Anaerobe; 2012 Feb; 18(1):37-43. PubMed ID: 22261518 [TBL] [Abstract][Full Text] [Related]
17. Susceptibility of anaerobic bacteria to five antimicrobial agents and demonstration of resistance of Bacteroides fragilis to clindamycin. Sofianou D; Douboyas J; Papapanagiotou J; Paradelis AG Methods Find Exp Clin Pharmacol; 1982; 4(3):173-7. PubMed ID: 7121128 [TBL] [Abstract][Full Text] [Related]
18. [Susceptibility to antimicrobial drugs of enterotoxin producing strains of Bacteroides fragilis isolated from different countries]. Obuch-Woszczatyński P; Rokosz A; Sawicka-Grzelak A; Pituch H; Meisel-Mikołajczyk F; Łuczak M Med Dosw Mikrobiol; 2002; 54(3):253-8. PubMed ID: 12632660 [TBL] [Abstract][Full Text] [Related]
19. In vitro activities of MK-0826 and 16 other antimicrobials against Bacteroides fragilis group strains. Betriu C; Sánchez A; Palau ML; Gómez M; Picazo JJ Antimicrob Agents Chemother; 2001 Aug; 45(8):2372-4. PubMed ID: 11451700 [TBL] [Abstract][Full Text] [Related]
20. In vitro activities of doripenem, a new broad-spectrum carbapenem, against recently collected clinical anaerobic isolates, with emphasis on the Bacteroides fragilis group. Snydman DR; Jacobus NV; McDermott LA Antimicrob Agents Chemother; 2008 Dec; 52(12):4492-6. PubMed ID: 18838581 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]